{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-056363","form_type":"8-K","ticker":"DNLI","cik":"0001714899","company_name":"Denali Therapeutics Inc.","filed_at":"2025-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.241202+00:00","generated_at":"2026-05-16T13:39:10.146376+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Denali prices $200M public offering of common stock and pre-funded warrants","bullets":["Prices 9.14M shares at $17.50 and 2.29M pre-funded warrants at $17.49, raising ~$200M gross proceeds.","Underwriters granted 30-day option for additional 1.71M shares, potential total $230M gross proceeds.","Offering expected to close Dec 11, 2025; Goldman Sachs, J.P. Morgan, Morgan Stanley, Jefferies as joint book-runners.","Pre-funded warrants have $0.01 exercise price, immediately exercisable, with 4.99% beneficial ownership limitation."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-056363","json":"https://secwatch.observer/filing/0001628280-25-056363.json","markdown":"https://secwatch.observer/filing/0001628280-25-056363.md","text":"https://secwatch.observer/filing/0001628280-25-056363.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1714899/000162828025056363/0001628280-25-056363-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1714899/000162828025056363/dnli-20251209.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:39:10.146376+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}